SCHEMBL1594812

SCHEMBL1594812

CCC[C@@H](c1ccc(C(F)(F)F)cc1)[C@@H](CO)N(C(=O)O)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.39
CES2 O00748 1/20 0.37
CES1 P23141 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
PDPK1 O15530 1/20 0.36
CYP3A4 P08684 4/20 0.36
UTS2R Q9UKP6 2/20 0.36
CYP1A2 P05177 3/20 0.35
CYP2C9 P11712 3/20 0.35
TSHR P16473 3/20 0.35
CYP2C19 P33261 3/20 0.35
GSK3B P49841 1/20 0.35
FFAR1 O14842 3/20 0.35
TAS1R3 Q7RTX0 1/20 0.35
TAS1R1 Q7RTX1 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
LMNA P02545 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1742950 0.85 CES2 (0.37) CES2CES1PDPK1UTS2RGSK3B
SCHEMBL2544467 0.85 CES2 (0.37) CES2CES1PDPK1UTS2RGSK3B
SCHEMBL1742949 0.85 CES2 (0.37) CES2CES1PDPK1UTS2RGSK3B
SCHEMBL2548060 0.84 AKR1C3 (0.37) CES2CES1PDPK1CYP3A4UTS2R
SCHEMBL1595216 0.84 AKR1C3 (0.37) CES2CES1PDPK1CYP3A4UTS2R
SCHEMBL1595011 0.82 AKR1C3 (0.40) CES2CES1FFAR1AKR1C3AKR1C2
SCHEMBL1595880 0.79 AKR1C3 (0.39) CES2CES1PPARGPPARACYP3A4
SCHEMBL1594707 0.77 FFAR1 (0.34) CES2CES1PPARGUTS2RFFAR1
SCHEMBL1743844 0.77 FFAR1 (0.34) CES2CES1PPARGUTS2RFFAR1
SCHEMBL2549587 0.77 FFAR1 (0.34) CES2CES1PPARGUTS2RFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7919504-B2 Thiadiazole modulators of PKB AMGEN INC. (US) 2011-04-05 US disclosed